UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053383
Receipt number R000060926
Scientific Title Novel nuclear imaging approach to assess perfusion and metabolism in chronic limb-threatening ischemia
Date of disclosure of the study information 2024/01/20
Last modified on 2024/01/18 11:17:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Developing nuclear imaging test in PAD

Acronym

Nuclear imaging in PAD

Scientific Title

Novel nuclear imaging approach to assess perfusion and metabolism in chronic limb-threatening ischemia

Scientific Title:Acronym

Nuclear imaging in CLTI

Region

Japan


Condition

Condition

peripheral artery disease

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to demonstrate proof-of-concept for a noninvasive method and novel parameters for assessing foot microcirculation and metabolism.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Limb fate including wound healing at 12-month

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

The patients with pedal tissue loss due to CLTI who have suspected coronary artery disease.

Key exclusion criteria

The patients with cognitive impairment.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takuya
Middle name
Last name Hashimoto

Organization

Saitama Medical Center, Saitama Medical University

Division name

Vascular Surgery

Zip code

3500844

Address

1981 Kamoda, Kawagoe-city, Saitama, Japan

TEL

0492283400

Email

takuya@saitama-med.ac.jp


Public contact

Name of contact person

1st name Takuya
Middle name
Last name Hashimoto

Organization

Saitama Medical Center, Saitama Medical University

Division name

Vascular Surgery

Zip code

3500844

Address

1981 Kamoda, Kawagoe-city, Saitama, Japan

TEL

0492283400

Homepage URL


Email

takuya@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Japanese Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Saitama Medical University

Address

38 Moro-Hongo, Moroyama-Town, Iruma-District, Saitama

Tel

049276214

Email

rinri@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 01 Month 04 Day

Date of IRB

2020 Year 01 Month 09 Day

Anticipated trial start date

2020 Year 02 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Single center prospective cohort pilot study is planned. The lower limbs of the patients diagnosed with CLTI are subjected to radionuclide angiography and SPECT. Novel parameters is derived by processing the time activity curve of detected tracers at each region of interest in the limbs. The association of these two parameters with limb fate at one year is analyzed. The association with the transcutaneous partial oxygen pressure, a conventional perfusion test result, is analyzed.


Management information

Registered date

2024 Year 01 Month 18 Day

Last modified on

2024 Year 01 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060926


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name